Revance Story

<div class='circular--portrait' style='background:#800000;color: #F8F8FF;font-size:4em;'>RT</div>
RVNC -- USA Stock  

USD 28.25  1.80  6.81%

Revance Stock News module provides quick insight into current market opportunities from investing in Revance Therapeutics. Use historical and current headlines to determine the investment entry and exit points. Many technical investors use Revance Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly. Additionally, take a look at Revance Therapeutics Hype Analysis, Revance Therapeutics Correlation and Revance Therapeutics Performance.
Search Today's Stock News ... 
Refresh
Revance Therapeutics stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Revance daily returns and investor perception about the current pice of Revance Therapeutics as well as its diversification or hedging effects on your existing portfolios.
Revance Therapeutics exotic insider transaction detected
Filed transaction by Revance Therapeutics Inc director. Unconventional Insider trading

Revance insider trading alert for general transaction of common stock by Rankin Aubrey, President Innovation & Tech, on 30th of October 2020. This event was filed by Revance Therapeutics Inc with SEC on 2020-10-30. Statement of changes in beneficial ownership - SEC Form 4

Cash Floor Correlation

Click cells to compare fundamentals   

Shares Owned by Institutions

Shares Owned by Institutions Comparative Analysis

Revance Therapeutics is currently under evaluation in shares owned by institutions category among related companies. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

Peers

Revance Therapeutics Related Equities

BGNEBeiGene   17.52   
0%
100.0%
SGENSeattle Genetics   10.71   
0%
61.0%
INCYIncyte   8.06   
0%
46.0%
VRTXVertex Pharmaceuticals Incorpor   7.13   
0%
40.0%
REGNRegeneron Pharmaceuticals   6.33   
0%
36.0%
WXIBFWUXI BIOLOGICS INC   5.44   
0%
31.0%
NVONovo Nordisk AS   4.59   
0%
26.0%
ALXNAlexion Pharmaceuticals   3.62   
0%
20.0%
WXXWYWUXI BIOLOGICS INC   3.22   
0%
18.0%
CSLLYCSL   2.73   
0%
15.0%
Additionally, take a look at Revance Therapeutics Hype Analysis, Revance Therapeutics Correlation and Revance Therapeutics Performance. Note that the Revance Therapeutics information on this page should be used as a complementary analysis to other Revance Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.